Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
- PMID: 18332118
- PMCID: PMC2423159
- DOI: 10.1128/MCB.02041-07
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
Abstract
Cell culture studies have implicated the oxygen-sensitive hypoxia-inducible factor (HIF) prolyl hydroxylase PHD3 in the regulation of neuronal apoptosis. To better understand this function in vivo, we have created PHD3(-/-) mice and analyzed the neuronal phenotype. Reduced apoptosis in superior cervical ganglion (SCG) neurons cultured from PHD3(-/-) mice is associated with an increase in the number of cells in the SCG, as well as in the adrenal medulla and carotid body. Genetic analysis by intercrossing PHD3(-/-) mice with HIF-1a(+/-) and HIF-2a(+/-) mice demonstrated an interaction with HIF-2alpha but not HIF-1alpha, supporting the nonredundant involvement of a PHD3-HIF-2alpha pathway in the regulation of sympathoadrenal development. Despite the increased number of cells, the sympathoadrenal system appeared hypofunctional in PHD3(-/-) mice, with reduced target tissue innervation, adrenal medullary secretory capacity, sympathoadrenal responses, and systemic blood pressure. These observations suggest that the role of PHD3 in sympathoadrenal development extends beyond simple control of cell survival and organ mass, with functional PHD3 being required for proper anatomical and physiological integrity of the system. Perturbation of this interface between developmental and adaptive signaling by hypoxic, metabolic, or other stresses could have important effects on key sympathoadrenal functions, such as blood pressure regulation.
Figures









Similar articles
-
Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions.J Leukoc Biol. 2014 Sep;96(3):365-75. doi: 10.1189/jlb.2HI1013-533R. Epub 2014 Mar 13. J Leukoc Biol. 2014. PMID: 24626957 Free PMC article.
-
Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.J Biol Chem. 2012 May 11;287(20):16975-86. doi: 10.1074/jbc.M111.334466. Epub 2012 Mar 26. J Biol Chem. 2012. PMID: 22451659 Free PMC article.
-
Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.J Mol Cell Cardiol. 2015 Mar;80:156-65. doi: 10.1016/j.yjmcc.2015.01.007. Epub 2015 Jan 26. J Mol Cell Cardiol. 2015. PMID: 25633836 Free PMC article.
-
The regulation, localization, and functions of oxygen-sensing prolyl hydroxylase PHD3.Biol Chem. 2013 Apr;394(4):449-57. doi: 10.1515/hsz-2012-0330. Biol Chem. 2013. PMID: 23380539 Review.
-
Regulation of gene expression by the hypoxia-inducible factors.Mol Interv. 2002 Jul;2(4):229-43. doi: 10.1124/mi.2.4.229. Mol Interv. 2002. PMID: 14993394 Review.
Cited by
-
The role of HIF prolyl hydroxylases in tumour growth.J Cell Mol Med. 2010 Apr;14(4):758-70. doi: 10.1111/j.1582-4934.2010.01030.x. Epub 2010 Feb 22. J Cell Mol Med. 2010. PMID: 20178464 Free PMC article. Review.
-
Prolyl hydroxylase domain (PHD) 2 affects cell migration and F-actin formation via RhoA/rho-associated kinase-dependent cofilin phosphorylation.J Biol Chem. 2010 Oct 29;285(44):33756-63. doi: 10.1074/jbc.M110.132985. Epub 2010 Aug 27. J Biol Chem. 2010. PMID: 20801873 Free PMC article.
-
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16997-17006. doi: 10.1073/pnas.1900748116. Epub 2019 Aug 2. Proc Natl Acad Sci U S A. 2019. PMID: 31375625 Free PMC article.
-
Global analysis of gene expression in NGF-deprived sympathetic neurons identifies molecular pathways associated with cell death.BMC Genomics. 2011 Nov 8;12:551. doi: 10.1186/1471-2164-12-551. BMC Genomics. 2011. PMID: 22067274 Free PMC article.
-
The PHD1 oxygen sensor in health and disease.J Physiol. 2018 Sep;596(17):3899-3913. doi: 10.1113/JP275327. Epub 2018 Mar 5. J Physiol. 2018. PMID: 29435987 Free PMC article. Review.
References
-
- Appelhoff, R. J., Y. M. Tian, R. R. Raval, H. Turley, A. L. Harris, C. W. Pugh, P. J. Ratcliffe, and J. M. Gleadle. 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 27938458-38465. - PubMed
-
- Aragones, J., M. Schneider, K. Van Geyte, P. Fraisl, T. Dresselaers, M. Mazzone, R. Dirkx, S. Zacchigna, H. Lemieux, N. H. Jeoung, D. Lambrechts, T. Bishop, P. Lafuste, A. Diez-Juan, S. K. Harten, P. Van Noten, K. De Bock, C. Willam, M. Tjwa, A. Grosfeld, R. Navet, L. Moons, T. Vandendriessche, C. Deroose, B. Wijeyekoon, J. Nuyts, B. Jordan, R. Silasi-Mansat, F. Lupu, M. Dewerchin, C. Pugh, P. Salmon, L. Mortelmans, B. Gallez, F. Gorus, J. Buyse, F. Sluse, R. A. Harris, E. Gnaiger, P. Hespel, P. Van Hecke, F. Schuit, P. Van Veldhoven, P. Ratcliffe, M. Baes, P. Maxwell, and P. Carmeliet. 2008. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40170-180. - PubMed
-
- Barker, D. J. 2002. Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 13364-368. - PubMed
-
- Barker, D. J., S. P. Bagby, and M. A. Hanson. 2006. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol. 2700-707. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases